Karuna Therapeutics Inc. (KRTX) Misses Q3 EPS by 27c
Tweet
Share
E-mailGet Alerts KRTX Hot Sheet
Join SI Premium – FREE
Karuna Therapeutics Inc. (NASDAQ: KRTX) reported Q3 EPS of ($2.38), $0.27 worse than the analyst estimate of ($2.11). Revenue for the quarter came in at $81 thousand.
For earnings history and earnings-related data on Karuna Therapeutics Inc. (KRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Medtronic jumps on earnings beat and raised guidance
- MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
